Increased expression of Fas ligand in human tuberculosis and leprosy lesions: a potential novel mechanism of immune evasion in mycobacterial infection

被引:40
|
作者
Mustafa, T
Bjune, G
Jonsson, R
Pando, RH
Nilsen, R
机构
[1] Univ Bergen, Ctr Int Hlth, N-5021 Bergen, Norway
[2] Univ Bergen, Dept Odontol, N-5021 Bergen, Norway
[3] Univ Bergen, Broegelmann Res Lab, N-5021 Bergen, Norway
[4] Univ Oslo, Dept Int Hlth, N-0317 Oslo, Norway
[5] Inst Nacl Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico
[6] Armauer Hansen Res Inst, Addis Ababa, Ethiopia
关键词
D O I
10.1046/j.1365-3083.2001.01020.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To study the location and mechanism of apoptosis within the human tuberculosis (TB) and leprosy lesions, parallel sections were analyzed for mycobacterial antigens (M.Ag), Fas ligand (FasL), Fas, CD68 and Mac387 by immunohistochemistry, and apoptotic cells by the terminal deoxynucleotidyl-transferase-mediated dUTP-digoxigenin nick end labelling method. Cutaneous leishmaniasis and foreign body granulomas were analyzed for comparison. The heavily infected macrophages in multibacillary TB and leprosy granulomas very strongly expressed FasL, indicating that a mycobacterial infection can induce an increased expression of FasL in a population of infected macrophages, which may protect them from the attack of Fas-expressing lymphocytes. However, macrophages with high levels of leishmania amastigotes did not selectively express FasL, suggesting that this phenomenon is specific for the mycobacteria. Interestingly, in the well-formed TB granulomas, 84% of the multinucleated giant cells strongly expressed FasL. The expression of Fas was weak (34%) or absent. A higher number (33%) of epithelioid cells expressed FasL than Fas (23%). Lymphocytes were scanty among the epithelioid cells. The frequency of apoptotic cells was higher in the epithelioid cells (0.25%) than the mononuclear cells in the mantle zone (0.14%). Thus, the epithelioid cells and the multinucleated giant cells by virtue of the increased expression of FasL may make these granulomas an immune privileged site for mycobacteria.
引用
收藏
页码:630 / 639
页数:10
相关论文
共 22 条
  • [1] Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages:: A potential novel mechanism of immune evasion by Mycobacterium tuberculosis?
    Mustafa, T
    Phyu, S
    Nilsen, R
    Bjune, G
    Jonsson, R
    INFLAMMATION, 1999, 23 (06) : 507 - 521
  • [2] Increased Expression of Fas Ligand on Mycobacterium tuberculosis Infected Macrophages: A Potential Novel Mechanism of Immune Evasion by Mycobacterium tuberculosis?
    Tehmina Mustafa
    Sabai Phyu
    Rune Nilsen
    Gunnar Bjune
    Roland Jonsson
    Inflammation, 1999, 23 (6) : 507 - 521
  • [3] Fas ligand expression in thyroid carcinomas: A potential mechanism of immune evasion
    Mitsiades, N
    Poulaki, V
    Mastorakos, G
    Tseleni-Balafouta, S
    Kotoula, V
    Koutras, DA
    Tsokos, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08): : 2924 - 2932
  • [4] The Fas/Fas‐ligand system: a mechanism for immune evasion in human breast carcinomas
    Linda S. Gutierrez
    Mariel Eliza
    Tracy Niven‐Fairchild
    Frederick Naftolin
    Gil Mor
    Breast Cancer Research and Treatment, 1999, 54 : 245 - 253
  • [5] The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas
    Gutierrez, LS
    Eliza, M
    Niven-Fairchild, T
    Naftolin, F
    Mor, G
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (03) : 245 - 253
  • [6] A novel mechanism of tumor immune evasion through Fas ligand bearing exosomes
    Ichim, TE
    Wang, XM
    Li, M
    O'Brien, CA
    Zhong, R
    Chin, JL
    Min, WP
    FASEB JOURNAL, 2004, 18 (04): : A67 - A67
  • [7] Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
    O'Connell, J
    Bennett, MW
    O'Sullivan, GC
    Roche, D
    Kelly, J
    Collins, JK
    Shanahan, F
    JOURNAL OF PATHOLOGY, 1998, 186 (03): : 240 - 246
  • [8] Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer
    Bennett, MW
    O'Connell, J
    O'Sullivan, GC
    Roche, D
    Brady, C
    Kelly, J
    Collins, JK
    Shanahan, F
    GUT, 1999, 44 (02) : 156 - 162
  • [9] CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes: A possible mechanism of immune evasion in chronic active EBV infection
    Ohshima, K
    Suzumiya, J
    Sugihara, M
    Nagafuchi, S
    Ohga, S
    Kikuchi, M
    PATHOLOGY INTERNATIONAL, 1999, 49 (01) : 9 - 13
  • [10] Expression of Fas ligand in advanced human atherosclerotic lesions: Implications for co-occurrence of immunocytoxicity and immune privilege
    Geng, YJ
    Liao, HS
    Magovern, J
    CIRCULATION, 1998, 98 (17) : 48 - 48